IMGN sells 29.9M* shares @$12.50—a 2% premium to yesterday’s close: https://finance.yahoo.com/news/immunogen-announces-pricing-upsized-public-234500092.html Net proceeds after underwriting fees from this upsized offering will about $350M*. *Assuming exercise of underwriter’s option.